Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aligos Therapeutics (ALGS) Prepaid Assets (2020 - 2025)

Aligos Therapeutics filings provide 6 years of Prepaid Assets readings, the most recent being $4.9 million for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 3.61% to $4.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.9 million, a 3.61% decrease, with the full-year FY2025 number at $4.9 million, down 3.61% from a year prior.
  • Prepaid Assets hit $4.9 million in Q4 2025 for Aligos Therapeutics, up from $4.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $13.5 million in Q4 2021 to a low of $3.4 million in Q2 2023.
  • Median Prepaid Assets over the past 5 years was $5.3 million (2023), compared with a mean of $6.1 million.
  • Biggest five-year swings in Prepaid Assets: soared 127.56% in 2021 and later plummeted 59.58% in 2023.
  • Aligos Therapeutics' Prepaid Assets stood at $13.5 million in 2021, then plummeted by 43.79% to $7.6 million in 2022, then plummeted by 30.16% to $5.3 million in 2023, then dropped by 4.11% to $5.1 million in 2024, then decreased by 3.61% to $4.9 million in 2025.
  • The last three reported values for Prepaid Assets were $4.9 million (Q4 2025), $4.2 million (Q3 2025), and $4.9 million (Q2 2025) per Business Quant data.